Colorectal
MULTI-001 Nivolumab v11
MULTI-003 Pembrolizumab v11
MULTI-014 Irinotecan & Capecitabine v1
MULTI-018 Larotrectinib v2
MULTI-019 Entrectinib v2
MULTI-022 Ipilimumab in combination with Nivolumab for CRC and RCC v3
MULTI-026 Trifluridine & Tipiracil (Lonsurf®) v1
MULTI-028 Regorafenib v1
MULTI-032 OXALIPLATIN & MOD de GRAMONT v1
COL-016 Irinotecan & MOD de GRAMONT v5
COL-030 Folfoxiri v2
COL-032 Capecitabine & oxaliplatin plus cetuximab v2
COL-033 Oxaliplatin, Mod de Gramont and Cetuximab v1
COL-041 Encorafenib and cetuximab v2
COL-042 Cetuximab in combination with FOLFOXIRI v1
COL-043 Panitumumab in combination with FOLFOXIRI v2
MULTI-003 Pembrolizumab v11
MULTI-014 Irinotecan & Capecitabine v1
MULTI-018 Larotrectinib v2
MULTI-019 Entrectinib v2
MULTI-022 Ipilimumab in combination with Nivolumab for CRC and RCC v3
MULTI-026 Trifluridine & Tipiracil (Lonsurf®) v1
MULTI-028 Regorafenib v1
MULTI-032 OXALIPLATIN & MOD de GRAMONT v1
COL-030 Folfoxiri v2
COL-032 Capecitabine & oxaliplatin plus cetuximab v2
COL-033 Oxaliplatin, Mod de Gramont and Cetuximab v1
COL-041 Encorafenib and cetuximab v2
COL-042 Cetuximab in combination with FOLFOXIRI v1
COL-043 Panitumumab in combination with FOLFOXIRI v2